This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,375.08 firm fixed-price delivery order is for the supply of 4,566,769 units of Pioglitazone HCL 30 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 20, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order falls under that larger IDC. No set-aside designation was used for this award.
Generated 3/23/25, 12:43 AM